SPONSOR
Fred Hutchinson Cancer Center
Total Trials
10
Recruiting
10
Phases
Phase 2, Phase 1, Phase 2, Phase 1
Conditions studied: Acute LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAdult Diffuse Large Cell LymphomaAnaplastic Large Cell LymphomaBurkitt LymphomaChronic Myeloid Leukemia, BCR-ABL1 PositiveChronic Myelomonocytic LeukemiaHodgkin LymphomaLymphoblastic Lymphoma
NCT04195633 Phase 2
Recruiting
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
Acute Leukemia
NCT04083183 Phase 1, Phase 2
Recruiting
Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases
Non-Malignant Neoplasm
NCT06817889 Phase 2
Recruiting
Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals
Hematopoietic and Lymphatic System Neoplasm
NCT04515810
Recruiting
Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning
Malignant Solid Neoplasm
NCT06928662 Phase 1, Phase 2
Recruiting
Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse
Acute Myeloid Leukemia
NCT04375631 Phase 1
Recruiting
CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
Recurrent Acute Myeloid Leukemia
NCT04829136
Recruiting
Sustained Oral Fiber Supplementation for Patients Undergoing Donor Stem Cell Transplantation for Hematological Malignancies
Hematopoietic and Lymphatic System Neoplasm
NCT07228624 Phase 2
Recruiting
Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes
Myelodysplastic/Myeloproliferative Neoplasm
NCT04370301 Phase 2
Recruiting
Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis
Primary Myelofibrosis
NCT03779854 Phase 2
Recruiting
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
Acute Biphenotypic Leukemia